Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00074308
Status:
COMPLETED
Last Update Posted:
2018-06-20
First Post:
2003-12-10
Brief Title:
Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers
Sponsor:
Organization:
National Cancer Institute NCI